This content is for healthcare professionals only.

This activity is funded by an independent medical education grant from Moderna, Inc.

This medical education is jointly provided by USF Health and touchIME.

Faculty & Disclosures

Listen on the go

    • View and download resources from this activity to support your learning and share with colleagues. Select a language to continue.

    Downloads
    Slides
    Fact Sheet
    Slides
    Fact Sheet
    Slides
    Fact Sheet
    CORRECT!
    Next question
    Faculty & Disclosures
    Dr Angus Thomson

    IRIMI company, Lyon, France

    Dr Angus Thomson is principal of IRIMI company, an organization concentrated on building public trust in public health programmes, with a focus on immunization. He is also adjunct clinical professor in the Department of Communication Studies & Global Health Communication Center, Indiana University School of Liberal Arts at IUPUI, Indianapolis, IN, USA. During the height of the pandemic, from April 2020 to May 2022, Dr Thomson was a consultant senior social scientist for the Demand for Immunization team at UNICEF. read more

    Dr Thomson has conceived and helped build a number of global vaccine demand programmes, including the Vaccination Demand Observatory, the International Pediatrics Association Vaccine Trust Project, and an international collaboration that validated the use of context-driven vaccine messaging on online platforms.

    Through collaborations with experts in social, behavioural and communication sciences, Dr Thomson’s team developed a suite of instruments to understand and measure attitudes to adult and healthcare professional vaccination. He co-developed the AIMS (Association for Improvements in the Maternity Services) mixed-learning behaviour-centred IPC (infection prevention and control) training programme for healthcare professionals. Having developed the 6As taxonomy of determinants of vaccination uptake, he has run national multi-stakeholder projects in Europe, Africa, the Middle East and Latin America that aim to improve vaccination uptake in national immunization programmes.

    Dr Thomson has published over 20 peer-reviewed opinion pieces, research papers and book chapters on vaccine confidence and coverage, and co-edited an 18-paper special issue on vaccine confidence in Vaccine. He co-authored the Vaccine Misinformation Management Field Guide and the Vaccine Messaging Guide, and led the digital information environment workstream of the Vaccination Demand Hub. He lectures on vaccine confidence for the VaxinLive Masters Program in Lyon and the Harvard School for Public Health vaccinology course.

    Dr Angus Thomson has no relevant financial disclosures in relation to this educational activity. 
    Dr Amaya Gillespie

    WHO/UNICEF, Jordan

    Dr Amaya Gillespie is a public health expert who has held senior leadership positions in the United Nations (UN) system, including under the UN Secretary General, World Health Organization, UNICEF and UNAIDS (Joint United Nations Programme on HIV/AIDS). read more

    Dr Gillespie’s grounding in public health and behavioural science has been the common thread throughout her career. She has a reputation as a leader in complex emergencies and public health issues (COVID-19, Ebola, HIV). She led the coordination of the COVID-19 response for the Middle East region in a joint role with the WHO and UNICEF, and most recently, supported Syria in the earthquake response in early 2023.

    Dr Amaya Gillespie has no relevant financial disclosures in relation to this educational activity.
    Dr Henry Kyobe Bosa

    Ministry of Health, Uganda

    Dr Henry Kyobe Bosa, an emerging infectious diseases epidemiologist, is the national incident commander for COVID-19 and Ebola virus in the Ministry of Health of Uganda. read more

    In this role, Dr Kyobe Bosa oversees the overall technical and operational nodes of the Ebola and COVID-19 response by the Ministry of Health in Uganda.

    Prior to this role, Dr Kyobe Bosa supported an African Union agency specializing in the development of sustainable financing mechanisms for outbreaks arising from emerging pathogens.

    Dr Kyobe Bosa has worked in public health emergencies for the past 16 years: from the Ebola outbreak in Bundibugyo in Uganda as a clinician, through to Sierra Leone and Ghana as an epidemiologist during the 2014/15 Ebola outbreak; and Mogadishu, Somalia, working on dengue viral haemorrhagic disease, and several other outbreaks in Uganda.

    Dr Kyobe Bosa is Uganda’s representative to the Africa Ebola Coordination Task Force (AfECT), a joint African Union/WHO AFRO coordinating mechanism. Dr Kyobe Bosa is a senior research scientist at Makerere University Lung Institute, and is a principal investigator on several ongoing studies. He is a co-principal investigator on the TEV Vaccine Trial.

    Dr Henry Kyobe Bosa has no relevant financial disclosures in relation to this educational activity. 
    Back to Faculty
    touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES
    Start activity
     
    Videos Take CE/CME Test
    COVID-19, Vaccines, Viral Infections, Respiratory Infections CE/CME accredited

    touchPANEL DISCUSSION
    A visually engaging discussion designed to emulate a ‘live’ panel experience and provide clinicians with practical expert insights to address their clinical challenges. Useful tips below will show how to navigate the activity. Close

    Reducing transmission of COVID-19: Spotlight on vaccines

    Useful tips
    • Select in the video player controls bar to choose subtitle language. Subtitles available in English, French, Turkish.
    • Downloads including slides are available for this activity in the Toolkit
    Learning Objectives

    After watching this activity, participants should be better able to:

    • Summarize the current COVID-19 vaccination landscape
    • Identify factors contributing to differential uptake of COVID-19 vaccines in population subsets
    • Evaluate strategies to improve COVID-19 vaccine uptake
    • Discuss the future of COVID-19 vaccination, including how vaccine inequity may be addressed
    Overview

    In this activity, three experts discuss the current landscape of COVID-19 vaccination, possible barriers to vaccine uptake and strategies involving healthcare workers that may help to improve acceptance of the COVID-19 vaccine, with a focus on Africa and the Middle East. The discussion is guided by pre-canvassed questions provided by respiratory and infectious diseases specialists and primary care providers working in Africa and the Middle East.

    This activity is jointly provided by USF Health and touchIME. read more

    Target Audience

    This activity has been designed to meet the educational needs of infectious disease specialists, respiratory disease specialists and primary care providers involved in the management of people with COVID-19 infection or the administration of the COVID-19 vaccines.

    Disclosures

    USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity.  The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.

    Faculty

    Dr Angus Thomson has no relevant financial disclosures in relation to this educational activity. 

    Dr Amaya Gillespie has no relevant financial disclosures in relation to this educational activity.

    Dr Henry Kyobe Bosa has no relevant financial disclosures in relation to this educational activity. 

    Content reviewer

    Sally F. Alrabaa, MD has no relevant financial disclosures in relation to this educational activity.

    Touch Medical Directors

    Hannah Fisher has no financial interests/relationships or affiliations in relation to this activity.

    USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.

    Requirements for Successful Completion

    In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.

    If you have questions regarding credit please contact cpdsupport@usf.edu.

    Accreditations

    Physicians

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

    USF Health designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    Advanced Practice Providers

    Physician Assistants may claim a maximum of 1.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

    The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.

    Date of original release: 26 April 2023. Date credits expire: 26 April 2024.

    If you have any questions regarding credit please contact cpdsupport@usf.edu.

    This activity is CE/CME accredited

    To obtain the CE/CME credit(s) from this activity, please complete this post-activity test.

    Claim Credit
    Useful tips
    • Select in the video player controls bar to choose subtitle language. Subtitles available in English, French, Turkish.
    • Downloads including slides are available for this activity in the Toolkit

    You may also be interested in...

    touchIN CONVERSATION

    Practical considerations for COVID-19 vaccination in the Middle East

    This activity is CE/CME accredited
    LAUNCH ACTIVITY

    touchPANEL DISCUSSION

    Reducing transmission of COVID-19: Spotlight on vaccines

    This activity is CE/CME accredited
    LAUNCH ACTIVITY

    JOURNALS

    Dementia and Cognitive Concerns as Risk Factors in People with COVID-19 and HIV

    GO TO ARTICLE

    JOURNALS

    Isolated Tuberculosis of the Ribs in an Immunocompetent Adult

    GO TO ARTICLE

    CONFERENCE HUB

    Evangelos Giamarellos-Bourboulis, ECCMID 2022: Long-term benefit of early anakinra treatment in COVID-19 pneumonia patients

    GO TO HUB

    CONFERENCE HUB

    Heiner Wedemeyer, EASL ILC 2021: Bulevirtide monotherapy in patients with chronic hepatitis D – Phase 3 MYR301 trial

    GO TO HUB

    Topics covered in this activity

    COVID-19 / Vaccines / Viral Infections / Respiratory Infections
    REGISTER NOW FOR FREE ACCESS TO
    • 1000+ topical and insightful peer-reviewed journal articles
    • 100+ hours of bite-sized congress highlights
    • 9 major therapy areas packed with the latest scientific advances
    • 150+ specialties offering learn-on-the-go medical education
    • + Concise email updates and newsletters so you never miss out
    Register For Free Now
    This Activity Is Funded By:

    An independent medical education grant from Moderna, Inc.
    This activity is jointly provided by USF Health and touchIME.

    The information provided by this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

    USF is an Equal Opportunity / Affirmative Action / Equal Access Institution.

    USF Health is accredited by the Accreditation Council for Continuing Medical Education, the American Nurses Credentialing Center and the Accreditation Council for Pharmacy Education to provide continuing education to healthcare professionals. As an accredited provider, USF Health is required to disclose personal information to relevant accredited bodies that certify CE to process credits/contact hours, comply with reporting requirements, and for internal recordkeeping and regulatory purposes. USF Health does not share or sell any individual’s contact information or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

    Unapproved products or unapproved uses of approved products may be discussed by the faculty; these situations may reflect the approval status in one or more jurisdictions. The presenting faculty have been advised by touchIME and USF Health to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by touchIME or USF Health of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in touchIME or USF Health activities. touchIME and USF Health accept no responsibility for errors or omissions.

    This content is intended for healthcare professionals.

    Date of original release: 26 April 2023. Date credits expire: 26 April 2024.

    Claim Credit
    touchPANEL DISCUSSION
    Reducing transmission of COVID-19: Spotlight on vaccines
    1.25 CE/CME credit
    Question 1/5
    As of March 2023, which of the following statements regarding COVID-19 vaccination is true?

    Globally, there remain major disparities in COVID-19 vaccine access and uptake. Africa and the Middle East are among the regions with the lowest number of people vaccinated. Within these regions, there are also large disparities. For example, as of January 2023, 106% of people in Qatar have received at least one dose of a COVID-19 vaccine, compared with only 26% of people in Iraq.

    Reference

    Our World In Data. Available at: www.ourworldindata.org/covid-vaccinations (accessed 15 March 2023).

    Question 2/5
    Based on the WHO SAGE roadmap for prioritizing the use of COVID-19 vaccines, which of the following groups would you prioritize for vaccination?

    SAGE, Strategic Advisory Group of Experts; WHO, World Health Organization.

    To assist countries in developing recommendations for optimized use of vaccines against COVID-19, the WHO has developed a roadmap that identifies three priority-use groups (high, medium and low) for vaccination based on epidemiological scenarios, public health goals and vaccine coverage scenarios. Within the roadmap, the high priority group includes older adults, younger adults with significant comorbidities, people with immunocompromising conditions, pregnant persons and frontline health workers.

    Abbreviation

    WHO, World Health Organization.

    Reference

    WHO. SAGE updates COVID-19 vaccination guidance. Available at: www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance (accessed 31 March 2023).

    Question 3/5
    You recommend the COVID-19 vaccine to a 60-year-old woman in your clinic. She has a general lack of trust in vaccines; however, after a lengthy discussion on the benefits of the COVID-19 vaccine, she agrees. She is a retired librarian who lives on her own; she has limited mobility and is unable to drive. Based on this information, which factors would you identify as her biggest barriers to vaccine uptake?

    Convenience of access to vaccination is related to increased vaccine uptake.1 In this scenario, the woman may find it difficult to attend her vaccine appointment due to her mobility issues and lack of personal transport.

    Acceptance is the degree to which individuals accept, question or refuse the vaccination.1 Effective strategies to tackle low trust in vaccines include recommendations from health professionals, vaccine champions and advocates, positive social norm messages and community engagement.2

    References

    1. Thomson A, et al. Vaccine. 2016;34:1018–24.
    2. WHO. Weekly Epidemiological Record. No 20. 2022;97:209–24.
    Question 4/5
    You work at a clinic in a rural town, 2 hours away from a major city. The majority of the community congregate at the local place of worship each Sunday. You are hearing that many people are hesitant to be vaccinated against COVID-19, and despite offering flexible opening hours at your clinic, you are still seeing a low vaccine uptake. How would you best approach increasing vaccine uptake in this population?

    Trustworthy figures (e.g. religious leaders) can play a major role in saving lives and reducing illness related to COVID-19 in a community. They are a primary source of support, comfort, guidance, and direct health care and social service, for the communities they serve. Religious leaders of faith-based organizations and communities of faith can share health information to protect their own members and wider communities, which may be more likely to be accepted than from other sources.

    Reference

    WHO. Practical considerations and recommendations for religious leaders and faith-based communities in the context of COVID-19. Available at: www.who.int/publications/i/item/practical-considerations-and-recommendations-for-religious-leaders-and-faith-based-communities-in-the-context-of-covid-19 (accessed 15 March 2023).

    Question 5/5
    Your region has high vaccination rates and is now considering how to integrate COVID-19 vaccination into a routine immunization programme. What would you suggest to optimize vaccination rates?

    The WHO and UNICEF published a joint report detailing the considerations for integrating COVID-19 vaccination into immunization programmes and primary healthcare for 2022 and beyond. Providing COVID-19 vaccination alongside other health interventions as a package of services, especially in the face of competing health priorities, will increase efficiency and programme performance.

    Abbreviations

    UNICEF, United Nations Children’s Fund; WHO, World Health Organization

    Reference

    WHO and UNICEF. Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond Available at: www.linkedimmunisation.org/wp-content/uploads/2022/08/Integration-of-Covid19-Vax_RI_PHC_WHO-UNICEF_Version-1_20220727.pdf (accessed 15 March 2023).

    Back to Activity

    You may also be interested in...

    CONFERENCE HUB

    Antiretroviral therapy updates at CROI 2024: emerging treatment strategies in HIV

    GO TO HUB

    touchTALKS

    COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in Africa and the Middle East?

    This activity is CE/CME accredited
    LAUNCH ACTIVITY

    touchPANEL DISCUSSION

    Shaping ART around individual needs: Maximizing adherence and quality of life

    LAUNCH ACTIVITY

    JOURNALS

    Foreword – touchREVIEWS in Infectious Diseases, Volume 1, Issue 1, 2022

    GO TO ARTICLE

    JOURNALS

    RECOVERY Trial Data on Baricitinib in Patients Hospitalized with Coronavirus Disease 2019

    GO TO ARTICLE

    CONFERENCE HUB

    Renslow Sherer, ACTHIV 2022: Long-term efficacy of mRNA vaccines in COVID-19, and the evidence in favour of booster vaccinations

    GO TO HUB
    This Activity Is Funded By:

    An independent medical education grant from Moderna, Inc.
    This activity is jointly provided by USF Health and touchIME.

    The information provided by this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

    USF is an Equal Opportunity / Affirmative Action / Equal Access Institution.

    USF Health is accredited by the Accreditation Council for Continuing Medical Education, the American Nurses Credentialing Center and the Accreditation Council for Pharmacy Education to provide continuing education to healthcare professionals. As an accredited provider, USF Health is required to disclose personal information to relevant accredited bodies that certify CE to process credits/contact hours, comply with reporting requirements, and for internal recordkeeping and regulatory purposes. USF Health does not share or sell any individual’s contact information or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

    Unapproved products or unapproved uses of approved products may be discussed by the faculty; these situations may reflect the approval status in one or more jurisdictions. The presenting faculty have been advised by touchIME and USF Health to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by touchIME or USF Health of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in touchIME or USF Health activities. touchIME and USF Health accept no responsibility for errors or omissions.

    This content is intended for healthcare professionals.

    Date of original release: 26 April 2023. Date credits expire: 26 April 2024.

    Faculty
    Podcast
    Featured
    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72